Senolytic Effect Biomarkers: p16, SA-β-Gal, and Circulating SASP Factors

Expert Summary

Clinical senolytic trials use a combination of tissue biomarkers (p16, p21, SA-β-Gal from biopsies) and circulating biomarkers (IL-6, MMP-3, MMP-9, GDF15 from blood) to assess treatment efficacy. For self-directed monitoring without biopsy access, circulating inflammatory markers (IL-6, hsCRP) and functional assessments (gait speed, grip strength) provide the most practical evidence of senolytic activity.

Key Facts

Recommended Products

Frequently Asked Questions

What's the most practical biomarker panel for monitoring my own senolytic protocol?

Start with: hsCRP, IL-6, and GDF15 from a commercial lab. These three capture different aspects of senescent cell burden at low cost. Measure before starting, after 3 months, and every 6 months ongoing.

Where can I get p16 mRNA testing?

Specialized companies including Life Length (telomere + senescence), TruDiagnostic (epigenetic age + inflammation), and some academic labs offer p16 blood testing. Standard commercial labs do not currently provide this.

Scientific References